legn

I-Legend Biotech (LEGN) iqambe u-Ingrid Zhang njengosihlalo omkhulu ngoLwesibili, yaqeda usesho lwezinyanga ezimbili olwaqala lapho owake waba yi-CEO, u-Ying Huang, esula ngoJulayi, futhi lwavula indlela yokwandisa okukunikezayo ngaphezu kwe-CARVYKTI, kanye nokulungiselela ukusabalala kokucatshangelwa ukuthengwa (buyout).
Inkampani ithe ukuqokwa kuka-CEO omusha kuqala ukusebenza ngokushesha. U-Alan Bash, owayeqhuba inkampani okwesikhashana, uzobuya emsebenzini wakhe njengomongameli we-CARVYKTI.
U-Zhang muva nje ubesebenza njengesikhulu esiphezulu sezentengiso (chief commercial officer) kwaNovartis International. Uphinde wahola ibhizinisi laseChina leNovartis kanye nenhlangano yalo yemithi esungulwayo, kanti futhi uchithe iminyaka ngaphambili e-AstraZeneca, Pfizer, nase-McKinsey. Usihlalo uFrank Zhang uthe ibhodi limkhethile ngemuva kosesho oluphelele ukuze liqondise iLegend esigabeni esilandelayo sokukhula. U-Zhang uthe ufuna ukwakha phezu kwesizinda senkampani sokwelashwa ngamaseli, aqhubekisele phambili ipayipi (pipeline), futhi afeze uhlelo lwesikhathi eside.